Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 26869049

Nab-paclitaxel versus solvent-based paclitaxel in neoadjuvant chemotherapy for early breast cancer (GeparSepto-GBG 69): a randomised, phase 3 trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet Oncol
Publication date
2016 Mar
First author
Untch M

This record carries publication-notice metadata. Review the notices below before relying on it.

Publication notices

absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2016 Mar;17(3):265-266. doi: 10.1016/S1470-2045(15)00566-5.
    note
    Source null
    related pmid
    26869050
    relationship
    Comment in
  2. citation
    Lancet Oncol. 2016 Jul;17(7):e270. doi: 10.1016/S1470-2045(16)30217-0.
    note
    Source null
    related pmid
    27733290
    relationship
    Erratum in
  3. citation
    Chin Clin Oncol. 2020 Jun;9(3):42. doi: 10.21037/cco.2019.12.06.
    note
    Source null
    related pmid
    32008327
    relationship
    Comment in

Authors and identifiers

  1. name
    Untch M
    type
    Author
  2. name
    Jackisch C
    type
    Author
  3. name
    Schneeweiss A
    type
    Author
  4. name
    Conrad B
    type
    Author
  5. name
    Aktas B
    type
    Author
  6. name
    Denkert C
    type
    Author
  7. name
    Eidtmann H
    type
    Author
  8. name
    Wiebringhaus H
    type
    Author
  9. name
    Kümmel S
    type
    Author
  10. name
    Hilfrich J
    type
    Author
  11. name
    Warm M
    type
    Author
  12. name
    Paepke S
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Untch M
    type
    Author
  2. name
    Jackisch C
    type
    Author
  3. name
    Schneeweiss A
    type
    Author
  4. name
    Conrad B
    type
    Author
  5. name
    Aktas B
    type
    Author
  6. name
    Denkert C
    type
    Author
  7. name
    Eidtmann H
    type
    Author
  8. name
    Wiebringhaus H
    type
    Author
  9. name
    Kümmel S
    type
    Author
  10. name
    Hilfrich J
    type
    Author
  11. name
    Warm M
    type
    Author
  12. name
    Paepke S
    type
    Author
bibliography ids
  1. nci-bib-4d5138f62c767189aad77ab5
book metadata
content sha256
25c985246ae64b150dba532c470ebf3521f844ef22a6a64e82c229371559a456
document type
citation
dois
  1. 10.1016/S1470-2045(15)00542-2
electronic publication date
display
2016 Feb 8
precision
day
year
2016
evidence scope
bibliographic_metadata_only
id
pubmed:26869049
immutable id
pubmed:26869049@25c985246ae64b150dba532c470ebf3521f844ef22a6a64e82c229371559a456
journal
abbreviation
Lancet Oncol
issn electronic
1474-5488
issn print
1470-2045
issue
3
name
The Lancet. Oncology
nlm unique id
100957246
pages
345-356
volume
17
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2016 Mar;17(3):265-266. doi: 10.1016/S1470-2045(15)00566-5.
    note
    Source null
    related pmid
    26869050
    relationship
    Comment in
  2. citation
    Lancet Oncol. 2016 Jul;17(7):e270. doi: 10.1016/S1470-2045(16)30217-0.
    note
    Source null
    related pmid
    27733290
    relationship
    Erratum in
  3. citation
    Chin Clin Oncol. 2020 Jun;9(3):42. doi: 10.21037/cco.2019.12.06.
    note
    Source null
    related pmid
    32008327
    relationship
    Comment in
outcomes validated
false
pmid
26869049
provenance
batch id
948d34b0dea86780a31d
provider
NCBI PubMed ESummary
record sha256
57a6034e6c51e60c39b7fe0231010bbf609b6ecf0c80c6f7b14a363befddde99
response sha256
11c34185eb9e4ea0d3c4d255d31806495349b0f097d492c4e135946541bf4bb5
retrieved at
2026-09-09T23:47:15.495091+00:00
publication date
display
2016 Mar
precision
month
year
2016
publication types
  1. Clinical Trial, Phase III
  2. Journal Article
  3. Multicenter Study
  4. Randomized Controlled Trial
  5. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/26869049/
title
Nab-paclitaxel versus solvent-based paclitaxel in neoadjuvant chemotherapy for early breast cancer (GeparSepto-GBG 69): a randomised, phase 3 trial.

Preserved source evidence · Not medical advice